Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
For full access to this article login to GEN Select now.
Microfluidics Making Bigger Impression
Techniques Evolve to Focus on Cells, Tissues, and Whole Organisms
- Microfluidics technology development is entering a new phase, according to Andreas Manz, Ph.D., head of research at the Korea Institute of Science and Technology, Saarbrücken, Germany. Now that the initial patents covering the fundamental technology have expired, companies can more easily and cost effectively acquire, develop, and apply microfluidics ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.